How Much Bacteriostatic Water for Thymosin Alpha-1? (Chart)

Determining Bacteriostatic Water Volume for Thymosin Alpha-1 Reconstitution

To reconstitute a standard 5 mg vial of Thymosin Alpha-1 5mg, researchers typically add between 1.0 mL and 2.5 mL of sterile bacteriostatic water (0.9% benzyl alcohol), yielding working concentrations between 5.0 mg/mL and 2.0 mg/mL respectively. The precise diluent volume selected is governed by the required final concentration of the stock solution for specific in vitro assays or analytical procedures, rather than a fixed universal requirement.

When preparing lyophilized peptides for bench work, lower diluent volumes (such as 1.0 mL) produce higher stock concentrations, which minimize the required pipetting volume during serial dilutions. Conversely, higher diluent volumes (such as 2.0 mL or 2.5 mL) increase volumetric margin, reducing relative pipetting error when dispensing micro-liter quantities. Investigators can use our online reconstitution calculator to compute custom mass, volume, and concentration variables beyond standard laboratory presets.

Thymosin Alpha-1 Reconstitution Diluent Volume Chart (5 mg Vial)

The table below outlines the concentration matrix achieved when reconstituting a standard 5 mg vial of research-grade Thymosin Alpha-1 with standard diluent volumes ranging from 1.0 mL to 5.0 mL of bacteriostatic water. These calculations assume full dissolution of the cake without volumetric displacement artifacts.

1.0 mL Diluent Addition: Yields a final concentration of 5.0 mg/mL (5.0 mcg/mcL). Adding 1.0 mL creates a concentrated stock solution ideal for high-throughput microplate assays where pipetting volume must remain strictly minimized.

2.0 mL Diluent Addition: Yields a final concentration of 2.5 mg/mL (2.5 mcg/mcL). Adding 2.0 mL offers a balanced working density, providing high accuracy across conventional P20 and P200 pipettors while maintaining stability in cold storage.

3.0 mL Diluent Addition: Yields a final concentration of 1.67 mg/mL (1.67 mcg/mcL). Adding 3.0 mL provides increased liquid volume for multi-well plate loading protocols requiring broader volumetric tolerances.

5.0 mL Diluent Addition: Yields a final concentration of 1.0 mg/mL (1.0 mcg/mcL). Adding 5.0 mL simplifies mental arithmetic during dose-response curve mapping, establishing a straightforward 1:1 milligram-to-milliliter base ratio.

Mathematical Framework for Reconstitution Arithmetic

Calculating the resulting concentration ($C$) of a reconstituted peptide requires applying the basic mass-volume formula: $C = m / V$, where $m$ represents the total peptide mass in milligrams (mg) and $V$ represents the volume of diluent added in milliliters (mL). To determine the mass per microliter ($ mcg/mcL), standard unit conversion scales milligrams directly to microgram equivalencies because $1\text{ mg/mL} = 1\text{ mcg/mcL}$.

For example, calculating the concentration of a 5 mg vial dissolved in 2.0 mL of bacteriostatic water follows: $5\text{ mg} / 2.0\text{ mL} = 2.5\text{ mg/mL}$. In in vitro organoid or cell line assays, where micro-volume additions are required, a 2.5 mg/mL solution equals 2.5 mcg per microliter. Consequently, extracting a 100 mcg sample for an assay culture requires pipetting exactly 40 mcL of the prepared stock solution ($100\text{ mcg} / 2.5\text{ mcg/mcL} = 40\text{ mcL}$).

Modifying diluent volume directly shifts the working concentration without altering total peptide mass. Researchers seeking step-by-step guidance on volumetric conversions across varying vial sizes can consult our comprehensive peptide reconstitution guide for expanded reference tables and lab protocols.

Physicochemical Characteristics of Thymosin Alpha-1 Lyophilized Powder

Thymosin Alpha-1 is an acetate salt of a synthetic 28-amino acid peptide, purified via modern solid-phase peptide synthesis (SPPS). In its lyophilized state, the sequence forms a stable, highly soluble powder cake. Understanding its physical properties ensures proper dissolution during reconstitution and prevents structural shear.

Because of its low molecular weight (~3,108 Da) and favorable hydropathicity profile, Thymosin Alpha-1 dissolves rapidly upon contact with aqueous diluents like bacteriostatic water. Unlike hydrophobic peptides that may require pH adjustments or co-solvents, Thymosin Alpha-1 reconstitutes cleanly into a clear, colorless solution. To verify sequence identity, purity, and exact molecular mass, researchers can download the lot-specific certificate of analysis provided for every PX1 batch.

Laboratory Handling, Aseptic Technique, and Aliquoting Guidance

Maintaining absolute sterility and structural integrity during reconstitution is vital to prevent bacterial contamination and peptide cleavage. Reconstitution must be performed within a certified laminar flow hood utilizing proper aseptic protocol. Standard diluent for multi-use laboratory vials is bacteriostatic water, containing 0.9% benzyl alcohol to inhibit microbial growth over extended storage periods.

When introduce bacteriostatic water into the vial, redirect the stream down the glass interior wall rather than directly onto the lyophilized cake. Allow the diluent to fully saturate the peptide matrix. Gently swirl the vial in a slow circular motion until completely dissolved; vigor or high-speed vortexing should strictly be avoided, as mechanical shear forces can introduce air bubbles and induce protein denaturing.

To prevent freeze-thaw degradation during long-term laboratory trials, the reconstituted solution should be immediately divided into single-use micro-aliquots using sterile microcentrifuge tubes. Aliquoting protects the bulk material from repeated thermal cycling, preserving peptide stability across sequential experimental runs.

Quality Assurance, Endotoxin Testing, and COA Verification

Analytical consistency is critical when conducting quantitative assays. PX1 Research manufactures all research compounds, including Thymosin Alpha-1, in state-of-the-art, GMP-compliant facilities located in the USA. Every lot undergoes rigorous quality testing within an ISO 17025 accredited analytical lab prior to release.

Purity is verified using High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS) to ensure a minimum purity threshold of 99%. In addition, every batch undergoes LAL assay testing to confirm endotoxin levels remain strictly under <0.1 EU/mg. This level of verification guarantees that observed cellular responses are attributable solely to the target sequence and not to pyrogenic contaminants. Researchers can view comprehensive catalog options across all research peptides for detailed compound specifications.

Comparative Analysis: Thymosin Alpha-1 alongside Related Immune-Modulating Compounds

In preclinical immune signaling research, Thymosin Alpha-1 is frequently evaluated alongside other peptide sequences derived from thymic tissue or involved in host defense pathways. Understanding how Thymosin Alpha-1 compares to related compounds helps investigators select the appropriate control or co-treatment for specific cell culture protocols.

While Thymosin Alpha-1 centers primarily on T-cell maturation markers and nuclear factor kappa B (NF-kB) pathways in vitro, TB-500 (Thymosin Beta-4) is studied primarily for its role in actin sequestration, cell migration, and tissue remodeling assays. Similarly, antimicrobial and immunomodulatory research often evaluates human cathelicidin LL-37 in membrane permeabilization assays, while anti-inflammatory studies explore the tripeptide sequence KPV. Comparing these distinct mechanisms allows researchers to construct robust, multi-target experimental matrices.

Assay Preparation and Volumetric Accuracy in In Vitro Protocols

In quantitative cell culture and enzyme assays, pipetting precision directly influences data reproducibility. Reconstituting Thymosin Alpha-1 into an optimal stock concentration ensures that aliquot transfers remain within the most accurate volumetric ranges of standard pipettes (typically 10% to 90% of total stroke capacity).

When preparing working solutions from a reconstituted 2.5 mg/mL stock, working serial dilutions should be prepared using sterile, buffered media (such as PBS or basal cell culture media) immediately prior to application. High-concentration stock solutions prevent excessive dilution of assay reagents, preserving media osmolarity and buffer capacity. Detailed research literature and technical briefs on peptide solubility are available in the PX1 research library.

Storage Stability and Cold-Chain Integrity Post-Reconstitution

Lyophilized Thymosin Alpha-1 maintains high stability when stored at -20°C in a desiccated, light-protected environment. Following reconstitution with bacteriostatic water (containing 0.9% benzyl alcohol), the resulting liquid solution remains stable at 2°C to 8°C for up to 28 days under sterile conditions.

For storage requirements exceeding 30 days, reconstituted micro-aliquots should be frozen at -20°C or -80°C. Repeated freezing and thawing of liquid peptide solutions accelerates peptide chain cleavage and aggregation. Always ensure vials are fully sealed and protected from exposure to direct light during storage.

Ordering High-Purity Research Compounds for Institutional Laboratories

Acquiring analytical-grade compounds with fully verified identity and purity is vital for reproducible experimental outcomes. PX1 Research supplies high-purity Thymosin Alpha-1, synthesized under strict quality controls and packaged under inert gas to ensure zero premature degradation.

We support university laboratories, biotechnology research organizations, and institutional facilities with rapid dispatch and transparent documentation. Orders placed before 12:00 PM PST ship same-day from our California and Arizona logistics centers. Institutional procurement departments interested in bulk quantities or custom vial sizing can submit inquiries through our dedicated bulk laboratory purchasing portal.